Navigation Links
Genes Found To Help Leukemia Treatment

When devising a treatment plan for Leukemia , doctors rely on indicators to decide how aggressive the cancer is likely to be, // including how the cancer cells look under a microscope, the patient’s age, and disease history. However, for some patients, those indicators are not enough to place them in a high-risk or low-risk group. Doctors may be left guessing which treatments to try.

Researchers have uncovered 133 genes that point to the most dangerous strains of adult leukemia. They say that this discovery may help doctors pick the best treatment for their patients, specifically by identifying cancer patients who need aggressive therapy.

Researchers have determined the minimal numbers of genes needed to identify important gene clusters linked to leukemia. In addition, they identified a unique cluster with a distinctive gene-expression that includes cases of leukemia with a poor treatment outcome.

Researchers say they also found some of the genes activated differently between the high-risk and intermediate-risk groups that were not previously known to be involved in acute myeloid leukemia. Studying these genes and their proteins could lead to new treatments for the disease, investigators conclude.
'"/>




Page: 1

Related medicine news :

1. New Way to "See" Genes, Evaluate Effectiveness of Gene Therapies Discovered
2. Genes for lung disease
3. Genesis of SUPAC
4. Genes for Vision discovered
5. Cardiac Valve Disease Linked To Genes
6. Genes Linked To Cigarette Addiction
7. Genes from saliva may predict oral and breast cancer
8. Genes More Important Than Exercise for Bad Cholesterol
9. Genes responsible for social behavior of us
10. Genes to Extend Longevity Discovered
11. Genes responsible for cancer in women associated with increased cancer risk in men

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Genes Found Help Leukemia Treatment

(Date:11/27/2009)... Voyant Health™ announced today tha...ensed its TraumaCad Enterprise orthopedic templati...tion. , (PRWEB) November ...hat Spectrum Health (Grand Rapids, Michigan) has l...ting solution and its TraumaCad Extend workflow so...
(Date:11/27/2009)... Specialist manufacturers who use medical...ing millions of dollars by bringing in technology ...asing numbers of pro-active medical manufacturers ...ncept stage of their projects, ensuring that progr...cesses or potentially outdated technology. , ...
(Date:11/26/2009)...Nov.27/PRNewswire/--Withcoldandfluseasonuponus,it,...olthespreadofinfectionsandavoidillness. ,, "Wen...oavoidtransmittingillnessifwe,resick,"saidEileenFi...ingdirectorforinfectioncontrolandoccupationalhealt..., HospitalforSpecialSurgeryhasoneofthelowestinfect...
(Date:11/26/2009)... years, the number of Americans living with diabet...n in 2009 to 44.1 million in 2034. Over the same p...sing from $113 billion to $336 billion, even with ...ers based at the University of Chicago report in t...er of those with diabetes covered by Medicare will...
(Date:11/26/2009)...oo big or too heavy can lead to strains or worse ,... There may be nothing wrong with stuffing your tur... the same thing with your suitcase as you pack for...treated in 2008 in U.S. hospital emergency rooms, ...ties for luggage-related injuries, such as muscle ...
Breaking Medicine News(10 mins):Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Pack Right for the Holidays to Avoid the ER 2
...ccording to a recent study in the U.S, divorce aff... Fred Lorenz, who co-authored the report at Iowa S...ural Research, said: “What we found was that the a...s on mental health led to effects in physical heal...
... recent study reveals that 1-in-8 children with ty... The allergy to gluten, largely present in w...rized by intestinal cramping, pain, bloating, diar...ng-term effects on growth were restored. D...
... hospital in London has developed a flat computer ...es of methicillin-resistant staphylococcus // aure...fections that kill 5,000 people each year in Brita...ance to most penicillins. Research shows tha...
...ospital wards in some of Russia's most remote loca...ores of patients, almost exclusively men, have bee...ng as a result of drinking bootleg vodka. Hund...ost of the numerous victims taken to hospitals ove...
...easure your waist regularly, because the size of y...racting cardiovascular diseases, // according to n...n origin. According to Kamlesh Khunti, senior c...rently over half of women and two-thirds of men in...
...hile the government officials continue to extol th...ve taken to the streets to protest against the pol...ecounts tales of falling waiting lists and increas...isastrous policies. Pensioners and health staf...
Other Medicine News:Health News:New Flat Keyboard To Tackle Hospital Super Bug 2Health News:Russia Hit By Cheap Bootleg Vodka Epidemic 2Health News:Wide Differences between NHS staff and ministers 2
(Date:11/25/2009)...HAM,Mass.,Nov.25/PRNewswire/--AccordingtoMillenniu...hnologymarketintelligence,thenearly$3billionUSmark...owthoverthenextfiveyearsdespitetherecenteconomicsl...tfindsthatthismarketwillremainhighlydynamicoverthe...ddevicesinpreviouslyunderservedsegmentsofthetrauma...
(Date:11/25/2009)...T,TheNetherlandsandJOHANNESBURG,November25/PRNewsw...xisDiscoveryannouncedtoday,thattheyhavesignedacoll...rvices. , Pyxis,sworldclasscomputationalchemi...emba,sservicedivisiontoprovidemedicinaland,synthet...,internationalclientnetwork.iThembaPharmaceutical...
(Date:11/24/2009)...NE,Calif.,Nov.24/PRNewswire-FirstCall/--Endologix,...eatmentsforaorticdisorders,announcedtodaythatithas...hepatentinfringementlawsuitbroughtagainstitinOctob...sDistrictCourtinIndianapolis,Indiana. ,, Endolo...itedStatesPatentandTrademarkOffice(USPTO)conductsp...
Breaking Medicine Technology:US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2AMA Honors IL Ophthalmologist Manus C Kraff M D for Volunteer Eye Care for Military Members 60903 1AMA Honors IL Ophthalmologist Manus C Kraff M D for Volunteer Eye Care for Military Members 60903 2AMA Honors Medical Society Executives 60901 1AMA Honors Medical Society Executives 60901 2AMA Has Chance to Rescind Support of HR 3962 3B AMA Shout Out from Public Urges Doctors to Answer to PATIENTS Not AMA Leadership 60899 1
...--(BUSINESS WIRE)--May 2, 2007 - Acorda Therapeuti...om a Phase 3 clinical trial,of Fampridine-SR in pe...Academy of Neurology meeting. Andrew Goodman, M.D.... University of,Rochester, presented top-line resul...d clinician and subject global impressions.,Dr. Go...
...OD CITY, Calif., May 02, 2007 /PRNewswire-FirstCal...that a presentation was,made today at the 20th Int...held in Palm Springs, California, on a,non-nucleos...iscovered by Genelabs. , The oral presentation was...of Medicinal Chemistry at Genelabs, entitled,"GL59...
Other Medicine Technology:Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 2Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 3Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 4Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 5Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 6Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 7Genelabs Technologies Announces Presentation of Data on,Non-Nucleoside HCV Polymerase Inhibitor at 20th International,Conference on Antiviral Research Meeting 2Genelabs Technologies Announces Presentation of Data on,Non-Nucleoside HCV Polymerase Inhibitor at 20th International,Conference on Antiviral Research Meeting 3
Access Vitamin B12
...ked immunosorbent assay (ELISA) for the semi-quant... in human serum. The presence of ANA can be used i...oratory tests to aid in the diagnosis of rheumatic...gren's syndrome, scleroderma, and mixed connective...
...s that are compatible with multichannel pipettors,...ber of pipetting steps required to prepare and pla... Immuno Concepts for more information about this p... noted with an * after the catalog number and are ...
... to screen out patients negative for antinuclear a...mic rheumatic diseases such as Systemic lupus eryt...tive tissue disease, progressive systemic sclerosi... Raynaud's phenomenon. They can also be used in co...
Medicine Products: